‌

US Patent 11744943 Integrated insulin delivery system with continuous glucose sensor

Patent 11744943 was granted and assigned to Dexcom on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Dexcom

Current Assignee

Dexcom

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11744943

Patent Inventor Names

James H. Brauker

John Michael Dobbles

Aarthi Mahalingam

Apurv Ullas Kamath

Date of Patent

September 5, 2023

Patent Application Number

16852369

Date Filed

April 17, 2020

Patent Citations

‌

US Patent 7131967 Infusion device and driving mechanism for same

‌

US Patent 7134999 Optimized sensor geometry for an implantable glucose sensor

‌

US Patent 7136689 Device and method for determining analyte levels

‌

US Patent 7146202 Compound material analyte sensor

‌

US Patent 7150741 Programmable dose control module

‌

US Patent 7162290 Method and apparatus for blood glucose testing from a reversible infusion line

‌

US Patent 7166074 Reusable analyte sensor site and method of using the same

‌

US Patent 7168597 Aerosol metering valve

...

Patent Primary Examiner

‌

Manuel A Mendez

Systems and methods for integrating a continuous glucose sensor

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11744943 Integrated insulin delivery system with continuous glucose sensor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API